Cytokine levels and pathological characteristics of a patient with severe coronavirus disease 2019: a case report.
Cytokine levels and pathological characteristics of a patient with severe coronavirus disease 2019: a case report.
复制标题
2019年重症冠状病毒病患者细胞因子水平及病理特征:一例报告
DOI:
10.1097/cm9.0000000000001540
复制
发表时间:
2022-01-05
影响因子:
6.1
通讯作者:
Yu K
中科院分区:
文献类型:
--
作者:
Kang K;Gao Y;Zhao M;Fei D;Ye M;Gao Y;Yang W;Wang C;Liu H;Chang G;Kang X;Luo Y;Du X;Qi J;Tian L;Zhou M;Hao C;Yu K
To the Editor: The clinical spectrum of coronavirus disease 2019 (COVID-19) appears to be wide, ranging from asymptomatic to severe progressive pneumonia with respiratory failure, multiorgan failure, and even death. Here, we investigated the clinical and pathological characteristics of a patient who died from severe COVID-19. Our findings will facilitate a deeper understanding of the pathogenesis and progression of COVID-19 and improve clinical strategies to combat the disease.On January 23, 2020, a 57-year-old man without relevant history presented with fatigue and fever after attending a family party 2 days prior. Among the members of the family party, one relative had traveled from Wuhan. Over 9 days, the fever and cough developed, and the patient visited the emergency department. A throat swab was positive for severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) on real-time reverse-transcription polymerase chain reaction. He was admitted to the local hospital and received supportive therapies, anti-viral agents, atomized inhalation of interferon-g, and oxygen therapy. Cough, fever, and dyspnea further developed on February 8. He received non-invasive mechanical ventilation therapy. On February 18, he was transferred to a superior hospital with shortness of breath. His oxygenation index decreased to 85.8 mmHg, and invasive ventilation was initiated. Comprehensive treatment measures included antibiotic